April 2nd - 2012
Future presentation at the AUA 2012
AUA (American Urological Association) in Atlanta, GA, USA, 19 -23 may 2012.
François Giuliano will present 1 poster:
"Effects of Tadalafil or Tamsulosin on Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia and on Erectile Dysfunction: Results from an International, Double-Blind, Placebo-Controlled Trial"
M. Oelke, F. Giuliano, V. Mirone, D. Cox, L. Viktrup.
Pelvipharm will
be represented by Delphine Behr-Roussel at the AUA annual
meeting.
We warmly invite you to take this opportunity to learn more
about our services.
If you’d like to set up a specific meeting at any time
throughout the congress, please email staffpelvipharm@pelvipharm.com and we will be happy to discuss our results
with you and potential applications for you.
March 19th - 2012
Recently published paper in Archives of Sexual Behavior
Who, What, Where, When (and Maybe Even Why)? How the Experience of Sexual Reward Connects Sexual Desire,Preference, and Performance
Pfaus JG, Kippin T, Coria-Avila G, Gelez H, Afonso V, Ismail N, Parada M.
Arch Sex Behav. 2012 Feb;41(1):31-62.
March 1st - 2012
Recently published paper in European Urology
Minimal Effective Dose of Dysport and Botox in a Rat Model of Neurogenic Detrusor Overactivity.
Behr-Roussel D, Oger S, Pignol B, Pham E, Le Maux A, Chabrier PE, Caisey S, Compagnie S, Picaut P, Bernabé J, Alexandre L, Giuliano F, Denys P.
Eur Urol. 2012 May;61(5):1054-61.
February 10th - 2012
Bio-Europe Spring in Amsterdam, March 2012
Pelvipharm will be represented by Delphine Behr-Roussel at the next BIO-Europe Spring meeting in Amsterdam, March 19-21 2012. We warmly invite you to take this opportunity to learn more about our services.
If you’d like to set up a specific meeting at any time throughout the conference, please email staffpelvipharm@pelvipharm.com and we will be happy to assist you.
January 9th - 2012
Future presentations at the EAU 2012
Pelvipharm at the EAU (European Association of Urology) in Paris, France, 24 - 28 February 2012.
Pelvipharm will present 3 posters:
- "Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO)"
D. Behr-Roussel, S. Oger, B. Pignol, E. Pham, A. Le Maux, P.E. Chabrier, P. Picaut, S. Caisey, S. Compagnie, F. Giuliano, P. Denys. - "Evidence for a functional role of connexin 43 and 45 in human neurogenic detrusor overactivity"
V. Phe, D. Behr-Roussel, S. Oger, E. Chartier-Kastler, T. Ghoneim, T. Lebret, G. Karsenty, E. Comperat, P. Camparo, P. Validire, F. Giuliano. - "Spontaneous contractile activity of human neurogenic bladder strips: Can we predict a correlation with between clinical factors, urodynamics and histological features?"
V. Phe, S. Oger, D. Behr-Roussel, P. Denys, E. Comperat, F. Giuliano, E. Chartier-Kastler.
François Giuliano will present 1 poster: - "Effects of tadalafil (TAD) or tamsulosin (TAM) on erectile function in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from a multicenter, double-blind, randomized, placebo (PLA)-controlled 12-week study"
F. Giuliano; M. Oelke; V. Mirone; S. Watts; D. Cox; L. Viktrup
Delphine Behr-Roussel will chair the session 40 : "Sexual dysfunction: Basic research"
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
January 2nd - 2012
Season's Greetings from the team at PELVIPHARM
We wish for you the very best for the new year, and extend our sincerest gratitude for your interest in our preclinical services.
